Drug Discovery for SARS-CoV-2 Utilizing Computer-Aided Drug Design Approaches
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense RNA virus with an unusually large genome of approximately 30 kb. It is highly transmissible and exhibits broad tissue tropism. The third most pathogenic of all known coronaviruses, severe acute respiratory syndrome coro...
Saved in:
| Main Authors: | Jiao Guo, Yang Bai, Yan Guo, Meihua Wang, Xinxin Ji, Yang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | COVID |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-8112/5/3/32 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computer-aided discovery, design, and investigation of COVID-19 therapeutics
by: Chun-Chun Chang, et al.
Published: (2022-01-01) -
Braving the SARS-CoV-2 pandemic – Quandary of health-care workers
by: Arjun Gurmeet Singh, et al.
Published: (2020-01-01) -
The Race to Find COVID-19 Vaccine: So Near, Yet so Far!
by: Sonali Sachdeva, et al.
Published: (2020-10-01) -
Pneumonia complicated by SARS-coV-2 infection in three patients with ankylosing spondylitis who are on anti-TNF therapy: Case-based review
by: Serdar Kaymaz, et al.
Published: (2020-01-01) -
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
by: Atri Das, et al.
Published: (2023-10-01)